TP53 and acute myeloid leukemia: Among those frequently mutated genes, ASXL1, RUNX1, TP53, and FLT3-ITD mutations have been associated with poor prognosis, whereas NPM1 mutations in the absence of FLT3-ITD have been associated with favorable outcomes in AML [43].